Sangamo Therapeutics Inc
SGMO0.460USD
+0.014+3.09%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
148.19MMarket Cap
LossP/E TTM
Sangamo Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
57.80M
-67.20%
EPS(YoY)
-0.49
67.15%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its total revenue reached 57.80M, with a year-on-year change of -67.20%.
What is the Earnings Per Share (EPS) of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.486, with a year-on-year change of 67.15%.
What is the net income of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its net income was -97.94M, with a year-on-year change of 62.01%.
What is the net margin of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its net profit margin was -169.45%, with a year-on-year change of -15.82%.
What is the gross margin of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -185.39%, with a year-on-year change of -35.85%.
What is the Return on Assets (ROA) of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -73.38%, with a year-on-year change of -3.57%.
What is the operating profit of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its operating profit was -98.15M, with a year-on-year change of 4.33%.
What are the current assets of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its current assets were 51.69M, with a year-on-year change of -45.20%.
What are the total assets of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its total assets of Sangamo Therapeutics Inc were 101.64M, with a year-on-year change of -38.52%.
What are the total liabilities of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its total liabilities of Sangamo Therapeutics Inc were 78.86M, with a year-on-year change of -4.33%.
What is the total equity of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its total equity of Sangamo Therapeutics Inc was 22.77M, with a year-on-year change of -72.53%.
What is the net operating income of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its net operating income of Sangamo Therapeutics Inc was -97.94M, with a year-on-year change of 62.01%.
What is the net investment of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its net investment of Sangamo Therapeutics Inc was 37.52M, with a year-on-year change of -75.56%.
What is the net financing of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2024 earnings report, its net financing of Sangamo Therapeutics Inc was 28.38M, with a year-on-year change of 94.52%.
